Principal Investigator
Eugene Schiff
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230573
Clinical Trial Summary
A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Fazirsiran in the Treatment of Alpha-1 Antitrypsin DeficiencyAssociated Liver Disease With METAVIR Stage F2 to F4 Fibrosis
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu